Group comparison of LRINEC, MELD and MELD-Na scores on admission, the extreme scores during hospitalization, and their differences.

Data are presented as mean ± SE, unless otherwise indicated.
† Wilcoxon rank sum test, unless otherwise indicated.
* The difference is significant (p < 0.05).
a LRINEC, laboratory risk indicator for necrotizing fasciitis.
b MELD, model for end-stage liver disease.
c MELD-Na, modified model for end-stage liver disease including sodium.
d Δ, difference between the admission and the extreme scores.
Group comparison of LRINEC, MELD and MELD-Na scores on admission, the extreme scores during hospitalization, and their differences.

除非另有说明，数据以平均值±标准误（SE）表示。
† 威尔科克森秩和检验，除非另有说明。
* 差异具有统计学意义（p < 0.05）。
a LRINEC：坏死性筋膜炎实验室风险指标（laboratory risk indicator for necrotizing fasciitis）
b MELD：终末期肝病模型（model for end-stage liver disease）
c MELD-Na：纳入血清钠的改良终末期肝病模型（modified model for end-stage liver disease including sodium）
d Δ：入院评分与住院期间极端评分的差值
针对入院时LRINEC、MELD及MELD-Na评分、住院期间极端评分及其差值开展组间比较。